Structure Therapeutics Inc.
GPCR
$21.76
$3.2317.43%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -36.48M | -33.98M | -26.03M | -26.04M | -24.50M |
| Total Depreciation and Amortization | 266.00K | 276.00K | 232.00K | 222.00K | 89.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 280.00K | 302.00K | 1.44M | -95.00K | -36.00K |
| Change in Net Operating Assets | -534.00K | 13.70M | -2.03M | -8.17M | 2.72M |
| Cash from Operations | -36.47M | -19.70M | -26.39M | -34.08M | -21.73M |
| Capital Expenditure | -16.00K | -685.00K | -427.00K | -162.00K | -1.16M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 33.25M | -188.36M | -204.09M | 1.58M | -179.59M |
| Cash from Investing | 33.23M | -189.04M | -204.52M | 1.42M | -180.74M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 615.00K | 397.00K | 515.29M | 755.00K | 300.12M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -1.15M | -589.00K | -53.00K | -18.49M |
| Cash from Financing | 615.00K | -757.00K | 514.70M | 702.00K | 281.63M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.62M | -209.50M | 283.80M | -31.96M | 79.16M |